复杂动脉瘤形态下使用主动固定型血管腔内动脉瘤修复术的结局
本研究纳入340例连续接受主动固定装置行EVAR的患者,其中234例使用肾下主动固定(AIF;Gore Excluder),106例使用肾上主动固定(ASF;85例Medtronic Endurant和21例Cook Zenith)。ASF组随访时间显著更短(25±17个月 vs 44.3±32个月;P<.0001),肾下瘤颈直径更大(25.9±6.3 mm vs 23.4±3.2 mm;P<.0001),动脉瘤直径更大(59.9±11.6 mm vs 55.9±10.0 mm;P=.002)。两组再干预、近端内漏、瘤囊增长、腹主动脉瘤相关死亡或破裂无显著差异。在ASF装置中,瘤颈直径>30 mm和非直瘤颈形态的再干预率最高。作者认为ASF可能对某些患者有用,但对宽瘤颈或多种困难瘤颈特征的患者可能不利,仍需进一步研究。
要点
- ASF组随访时间显著短于AIF组(25±17个月 vs 44.3±32个月;P<.0001)。
- 两组再干预、近端内漏、瘤囊增长、AAA相关死亡或破裂无显著差异。
- ASF装置中瘤颈直径>30 mm和非直瘤颈形态的再干预率最高。
核心结论
- 在复杂动脉瘤形态患者中,ASF似乎使用更频繁。
- 作者认为ASF可能对某些患者有用,但对宽瘤颈或多种困难瘤颈特征的患者可能不利。
- 作者指出仍需进一步研究以评估更优治疗选择,如开窗EVAR、分支EVAR及EndoAnchors等血管腔内辅助手段。
研究设计与样本
- 连续纳入340例接受主动固定装置行EVAR的患者,其中234例使用肾下主动固定(AIF;Gore Excluder),106例使用肾上主动固定(ASF;85例Medtronic Endurant和21例Cook Zenith)。
- 分析人口学、合并症、解剖特征和结局,并评估主动固定在瘤颈长度<15 mm、肾下瘤颈角度(β)>60度、肾下瘤颈直径>30 mm、严重主动脉瘤颈钙化或血栓及非直瘤颈形态中的结局。
主要发现
- ASF组随访时间显著短于AIF组(25±17个月 vs 44.3±32个月;P<.0001)。
- ASF组肾下瘤颈直径显著大于AIF组(25.9±6.3 mm vs 23.4±3.2 mm;P<.0001),动脉瘤直径显著大于AIF组(59.9±11.6 mm vs 55.9±10.0 mm;P=.002)。
- ASF组主动脉瘤颈长度短于AIF组(25.5±15.1 mm vs 28.6±14.9 mm;P=NS)。
- 两组再干预、近端内漏、瘤囊增长、腹主动脉瘤相关死亡或破裂无显著差异。
- 在ASF装置中,瘤颈直径>30 mm和非直瘤颈形态的再干预率最高。
临床怎么用
- 作者认为ASF可能对某些患者有用,但对宽瘤颈或多种困难瘤颈特征的患者可能不利。
- 作者指出仍需进一步研究以评估开窗EVAR、分支EVAR及EndoAnchors等更优治疗选择。
局限性
- ASF组随访时间显著短于AIF组(25±17个月 vs 44.3±32个月;P<.0001)。
- 作者指出仍需进一步研究以评估更优治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The ideal treatment option for patients with complex aneurysm morphology remains highly debated. The aim of this study was to investigate the impact of endovascular aneurysm repair (EVAR) with active fixation on outcomes in patients with complex aneurysm morphology. METHODS: There were 340 consecutive patients who underwent EVAR using active fixation devices, 234 with active infrarenal fixation (AIF; Gore Excluder; W. L. Gore & Associates, Flagstaff, Ariz) and 106 with active suprarenal fixation (ASF; 85 Medtronic Endurant [Medtronic, Santa Rosa, Calif] and 21 Cook Zenith [Cook Medical, Bloomington, Ind]). Demographics, comorbidities, anatomic features, and outcomes were analyzed for patients receiving devices with active fixation. Outcomes of using active fixation in necks with <15-mm neck lengths, >60-degree infrarenal neck angle (β), >30-mm infrarenal neck diameter, severe aortic neck calcification or thrombus, and nonstraight neck morphology were evaluated. RESULTS: Of the 340 patients, 106 (78 men; mean age, 74.5 ± 9.3 years at the time of surgery) received implants with ASF and 234 (191 men; mean age, 74.6 ± 8.9 years at the time of surgery) received implants with AIF. In comparing AIF and ASF devices, patients in the suprarenal fixation group had significantly shorter follow-up time (25 ± 17 months vs 44.3 ± 32 months; P < .0001). Patients in the ASF group had shorter aortic neck lengths (25.5 ± 15.1 mm vs 28.6 ± 14.9 mm; P = NS) and significantly larger infrarenal neck diameters (25.9 ± 6.3 mm vs 23.4 ± 3.2 mm; P < .0001) and aneurysm diameters (59.9 ± 11.6 mm v. 55.9 ± 10.0 mm; P = .002). Outcomes were similar between groups, with no significant differences in reintervention, proximal endoleak, sac growth, abdominal aortic aneurysm-related death, or rupture. Of the complex anatomic neck features investigated, neck diameter >30 mm and nonstraight neck morphology had the highest rates of reintervention in ASF devices. CONCLUSIONS: In cases of hostile infrarenal neck morphology, ASF appears to be used more frequently. Our data suggest that ASF may be useful for certain patients but may be unfavorable for others, such as those with wide necks or several difficult neck features. Nevertheless, further research is needed to evaluate more optimal treatment options, such as fenestrated EVAR, branched EVAR, and endovascular adjuncts such as EndoAnchors (Aptus Endosystems, Sunnyvale, Calif), in dealing with high-risk anatomic characteristics that may not be optimally managed with standard EVAR devices with active fixation.
引用
- Tadros RO, Sher A, Kang M, et al. Outcomes of using endovascular aneurysm repair with active fixation in complex aneurysm morphology. J Vasc Surg. 2018. PMID: 29548813. doi:10.1016/j.jvs.2017.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。